Al-Mowasat Medical Services Company, listed on the Saudi Stock Exchange, announced today, Monday, a significant step in its strategic expansion plans, confirming the completion of all necessary inspection, calibration, and testing of the mechanical and medical systems for its new hospital project in Yanbu Industrial City. This step paves the way for initiating the procedures to obtain the final licenses required to commence the project's actual operation.
Project details and financial investment
This project is one of the company's major investments in the Western Region, with Al-Mowasat having won the construction contract in June 2022. The total value of the contract was approximately SAR 295 million, as previously disclosed by the company on the Saudi Stock Exchange (Tadawul). The hospital is located in the Al-Sawari district of Yanbu Industrial City, a strategic location intended to serve the growing population and workforce in the industrial city.
The contract included the implementation of an integrated package of works, including architectural and construction aspects, as well as electrical, plumbing and mechanical works for all hospital facilities, ensuring the provision of an advanced medical environment that complies with the latest global standards in healthcare.
The strategic and economic importance of the project
This project is of particular importance given its location in Yanbu Industrial City, a major economic hub for the Kingdom of Saudi Arabia. The new hospital is expected to enhance the city's healthcare infrastructure and provide specialized medical services that previously required patients to travel to major cities like Jeddah or Medina. The project also reflects the private sector's commitment to contributing to the goals of Vision 2030, which focuses on improving quality of life and increasing private sector participation in healthcare delivery.
Expected impact and next steps
From an economic perspective, analysts expect the operation of this medical facility to positively impact Al-Mowasat Medical Company's financial statements as soon as it becomes fully operational, boosting its market share and diversifying its geographical revenue streams. The company stated that the official start date will be announced later, once final approvals are obtained from the Ministry of Health and other relevant authorities, ensuring the readiness of medical and administrative staff to provide optimal services to patients.
